VVO
Vivos Therapeuti
Stock
Stock
ISIN: US92859E2072
Ticker: VVOS
US92859E2072
VVOS
Price
Price
CHART BY
Frequently asked questions
What is Vivos Therapeuti's market capitalization?
The market capitalization of Vivos Therapeuti is $26.09M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Vivos Therapeuti?
Vivos Therapeuti's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.923. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Vivos Therapeuti's stock?
Currently, 2 analysts cover Vivos Therapeuti's stock, with a consensus target price of $4.225. Analyst ratings provide insights into the stock's expected performance.
What is Vivos Therapeuti's revenue over the trailing twelve months?
Over the trailing twelve months, Vivos Therapeuti reported a revenue of $14.63M.
What is the EBITDA for Vivos Therapeuti?
Vivos Therapeuti's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$10.69M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Vivos Therapeuti?
Vivos Therapeuti has a free cash flow of -$14.51M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Vivos Therapeuti have, and what sector and industry does it belong to?
Vivos Therapeuti employs approximately 109 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Vivos Therapeuti's shares?
The free float of Vivos Therapeuti is 3.76M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $26.09M
- EPS (TTM)
- -$1.923
- Free Float
- 3.76M
- Revenue (TTM)
- $14.63M
- EBITDA (TTM)
- -$10.69M
- Free Cashflow (TTM)
- -$14.51M
Pricing
- 52W span
- $1.98$6.28
Analyst Ratings
The price target is $4.225 and the stock is covered by 2 analysts.
Buy
1
Hold
1
Sell
0
Information
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
- Employees
- 109
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US92859E2072
- Primary Ticker
- VVOS
Fundamentals & EOD data from FactSet